Dental implant patient financing and case acceptance

Full-arch treatment is one of the largest discretionary purchases most patients will ever make, and very few write a check for it. That means the financial path is not an administrative detail that follows the clinical decision. For most patients it is the clinical decision, because without a path there is no treatment to decide about.

Practices that treat financing as paperwork tend to discover this late. The consultation goes well, the patient is enthusiastic, and then the conversation moves to the front desk, where it becomes a form rather than a conversation. The patient leaves to think and the case quietly ends. Nobody in the practice records it as a financing failure, because on the day it looked like an ordinary consultation that did not convert.

Practices that treat financing as part of the case presentation get a different result from the same patient, because the patient never has to work out alone whether this is possible for them. The treatment and the way of paying for it arrive together, as one recommendation, from someone who has already thought about their situation.

Earlier than most practices are comfortable with. The instinct is to build value first and protect the number until the end, which works reasonably well for treatment measured in hundreds and poorly for treatment measured in tens of thousands.

A patient given no sense of the range before arriving spends the consultation doing arithmetic instead of listening. By the time the number is said out loud, they have been rehearsing an exit for twenty minutes, and everything the doctor said in between has gone unheard.

A workable sequence

1. Before the visit, the patient learns that financial paths exist and hears a range rather than a quote.
2. At the consultation, the treatment is presented in full, clinically, and the recommendation is made.
3. The number is said plainly, once, without apology.
4. The financial options are presented as a choice, and the patient picks a direction rather than being asked to accept or decline.

This is why our Virtual Treatment Coordinators begin the financial conversation online, before the patient takes up chair time. The patient arrives having already had the uncomfortable part of the conversation with someone whose job it is to have it.

A single financial path turns the consultation into a yes or no question, and a patient who cannot take that one path has no option except to leave. A patient offered a genuine choice is making a different decision: which route, rather than whether at all.

This is the practical reason practices work with more than one financing partner. Patients arrive in different financial situations, and a practice with one option can only serve one of them.

What a real choice looks like

• More than one route, presented side by side rather than sequentially after a decline.
• Phased treatment as a legitimate option where it is clinically appropriate, rather than a consolation prize.
• A clear explanation of what each route means for the patient month to month, in their own numbers.
• A path that remains open if the patient wants to think, so nothing has to be restarted later.

Discuss the specifics of any financing product with the provider of that product. What belongs to the practice is the conversation, the ownership of it, and the follow-up.

The financial part of the consultation is where most avoidable losses happen, and the causes repeat from practice to practice.

Prejudging the patient

Teams form a view about what a patient can afford based on how they arrived, what they are wearing or where they live, and then present accordingly. The judgment is frequently wrong, and it is visible to the patient. Present the same treatment the same way to everyone and let the patient decide what they can do.

Apologizing for the number

Hedging, softening or rushing past the price tells the patient the practice does not believe in it. Say it once, clearly, and let it sit.

Handing the conversation to the front desk

The moment the financial conversation leaves the room it stops being part of the treatment decision and becomes a transaction. Whoever presents the plan should present the path to paying for it.

Stopping at the first no

A patient who cannot proceed down one route has declined only that route. Practices that treat that as declining treatment lose cases that were entirely winnable.

One person, named, trained, and present in the room when the plan is presented. In most practices that is the treatment coordinator. In some it is the doctor. Either can work, and dividing it between them rarely does.

That person needs to know every route the practice offers well enough to explain it conversationally, to answer the obvious questions without leaving the room, and to say the number without flinching. That is a skill rather than a personality, which means it can be taught to the person already doing the job.

ArchCore is the Dental Implant Machine playbook our account managers use to coach treatment coordinators and doctors on patient consultation and treatment case acceptance, including the financial part of that conversation, with a monthly review of how the practice is performing.

A practice can be generating patients well and still lose most of them financially, which shows up as a rising cost per started arch while the lead reports look healthy. That is a conversion and closing problem wearing a marketing costume, and adding budget makes it more expensive rather than better.

The connection runs the other way too. Advertising that speaks only to price attracts patients who are shopping on price, and advertising that hides the subject entirely attracts patients who have not begun to think about it. Neither produces good consultations.

This is why we manage campaigns against treatment starts rather than against the cheapest possible lead, and why financial readiness is part of qualifying a patient before they take one of your consultation slots. The measure we report is return on ad spend: practice-reported treatment value divided by ad spend.

Very few practices can say what their financing conversation is doing to their case acceptance, because nobody records it. The conversation happens dozens of times a month and leaves no trace in the practice management system. A handful of counts, kept weekly, make it visible.

• The share of consultations where a financial route was discussed in the room rather than at the desk.
• The share of patients who arrived already knowing the cost range.
• Cases that did not start for financial reasons, separated from cases that did not start for other reasons.
• Cases that started after a second conversation.

The fourth line is usually the surprise. Practices that begin following up on financial hesitation almost always find cases there that they had already written off, and they are the cheapest arches the practice will start all year, because the advertising that produced them has already been paid for.